P. K. Chaithanya, Vashista Maniar, Rakesh Taran, Rushabh Kiran Kothari, Velavan Kandappan, Rajnish Vasant Nagarkar, Nirali Nirav Trivedi, Aditi Harsh Thanky, Anil Kumar M R, Bhushan Tapiram Nemade, Gopichand Manillapalli, Shanti Prakash Shrivastav, Mahesh Kumar Veeranna Kalloli, Praveena Voonna, Sajjan Rajpurohit, Alpeshkumar Jayantilal Kikani, Hiten Saresa, Anil Rajani, Deepak Bunger, Alok Chaturvedi. "Efficacy, safety, and immunogenicity of pertuzumab biosimilar versus reference pertuzumab in combination with trastuzumab and docetaxel in HER2-positive metastatic breast cancer: A randomized, double-blind, multicenter, parallel group, phase III clinical trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1047